Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 61-70 of 98 for

Edit search filters
  1. Ursodiol on Insulin Sensitivity, Gastric Emptying and Body Weight With Type 2 Diabetes on Metformin

    Rochester, MN

  2. Control-IQ Technology in Individuals with Type 2 Diabetes

    Rochester, MN

  3. Intramyocellular Fatty Acid Trafficking in Insulin Resistance States - Effects of Intestinal Delivery of Lipids

    Rochester, MN

  4. A Study To Evaluate The Effectiveness And Safety Of Brolucizumab Vs. Aflibercept In Patients With Visual Impairment Due To Diabetic Macular Edema

    Jacksonville, FL

  5. Continuous Glucose Monitor (CGM) Use in COVID-19 Patients

    Jacksonville, FL

  6. Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease

    Rochester, MN

  7. A Study to Evaluate the Effectiveness and Safety of Remdesivir to Treat Coronavirus Disease 2019 in an Outpatient Setting

    Rochester, MN

  8. A Study To Evaluate The Safety And Effectiveness Of The Drug TTP399 To Target A1c In Type 2 Diabetics

    Rochester, MN

  9. Safety And Feasibility Of Novel Therapy For Duodenal Mucosal Regeneration For Type II Diabetes (REGENT-1-US)

    Rochester, MN

  10. Pharmacist Collaboration in the Care of Patients with Diabetes within the Primary Care Clinic Setting

    Rochester, MN

.

Mayo Clinic Footer